TY - JOUR
T1 - Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study
AU - Aguilar-Company, Juan
AU - Martín, María Teresa
AU - Goterris-Bonet, Lidia
AU - Martinez-Marti, Alex
AU - Sampol, Júlia
AU - Roldán, Elisa
AU - Almirante, Benito
AU - Ruiz-Camps, Isabel
PY - 2019/9
Y1 - 2019/9
N2 - © 2019 Blackwell Verlag GmbH The aim of this study was to describe the characteristics of patients with chronic pulmonary aspergillosis (CPA) in a tertiary care centre in Spain. Retrospective cohort study of all patients diagnosed with CPA between January 2010 and December 2015. The patients were identified through the Microbiology Registry. Demographic, clinical, laboratory, radiological, microbiological and clinical data were recorded. Patients were followed up for 12 months. Fifty-three patients were included; median age was 61.5 years. Forty-seven had a lung condition, 25 suffered from COPD, 19 an active malignancy, 10 had previous pulmonary tuberculosis and 9 lung interstitial disease. Twenty-eight patients presented with chronic cavitary pulmonary form (CCPA) and 20 with subacute invasive aspergillosis (SAIA). Species identified were A fumigatus (34), A niger (5), A terreus (4) and A flavus (3). All-cause 1-year mortality was 56%. Predictors of mortality were cancer history (OR, 9.5; 95% CI, 2.54-35.51; P < 0.01) and SAIA (OR, 5.49; 95% CI, 1.49-19.82; P < 0.01). Previous pulmonary tuberculosis, surgery for the treatment of CPA and CCPA were found to be associated with lower mortality (OR, 0.05; 95% CI, <0.01-0.47; P < 0.01; OR, 0.16; 95% CI, 0.03-0.88; P = 0.035 and OR 0.2, 95% CI, 0.01-0.67; P = 0.01, respectively). This is the first study providing an overview of the features of CPA in patients from Spain. CCPA was the most frequent form of CPA and A fumigatus the most frequently isolated species. Patients with cancer history and SAIA had a worse prognosis.
AB - © 2019 Blackwell Verlag GmbH The aim of this study was to describe the characteristics of patients with chronic pulmonary aspergillosis (CPA) in a tertiary care centre in Spain. Retrospective cohort study of all patients diagnosed with CPA between January 2010 and December 2015. The patients were identified through the Microbiology Registry. Demographic, clinical, laboratory, radiological, microbiological and clinical data were recorded. Patients were followed up for 12 months. Fifty-three patients were included; median age was 61.5 years. Forty-seven had a lung condition, 25 suffered from COPD, 19 an active malignancy, 10 had previous pulmonary tuberculosis and 9 lung interstitial disease. Twenty-eight patients presented with chronic cavitary pulmonary form (CCPA) and 20 with subacute invasive aspergillosis (SAIA). Species identified were A fumigatus (34), A niger (5), A terreus (4) and A flavus (3). All-cause 1-year mortality was 56%. Predictors of mortality were cancer history (OR, 9.5; 95% CI, 2.54-35.51; P < 0.01) and SAIA (OR, 5.49; 95% CI, 1.49-19.82; P < 0.01). Previous pulmonary tuberculosis, surgery for the treatment of CPA and CCPA were found to be associated with lower mortality (OR, 0.05; 95% CI, <0.01-0.47; P < 0.01; OR, 0.16; 95% CI, 0.03-0.88; P = 0.035 and OR 0.2, 95% CI, 0.01-0.67; P = 0.01, respectively). This is the first study providing an overview of the features of CPA in patients from Spain. CCPA was the most frequent form of CPA and A fumigatus the most frequently isolated species. Patients with cancer history and SAIA had a worse prognosis.
KW - Aspergillus infection
KW - chronic pulmonary aspergillosis
KW - fungal lung disease
KW - galactomannan
KW - immunocompromised host
KW - lung cancer
KW - Mycoses
KW - Prognosis
KW - Tertiary Care Centers
KW - Humans
KW - Middle Aged
KW - Pulmonary Aspergillosis/diagnosis
KW - Male
KW - Spain
KW - Aspergillus
KW - Female
KW - Lung Diseases/complications
KW - Neoplasms/complications
KW - Registries
KW - Aged
KW - Lung/microbiology
KW - Retrospective Studies
KW - Aspergillosis/complications
KW - Chronic Disease
UR - http://www.mendeley.com/research/chronic-pulmonary-aspergillosis-tertiary-care-centre-spain-retrospective-observational-study
U2 - 10.1111/myc.12950
DO - 10.1111/myc.12950
M3 - Article
C2 - 31162731
SN - 0933-7407
VL - 62
SP - 765
EP - 772
JO - Mycoses
JF - Mycoses
ER -